UroGen Pharma Ltd. Income Statement
URGN / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 10 fiscal years. All figures from audited SEC 10-K filings.
UroGen Pharma Ltd. reported $110M in revenue and $153M in net loss for FY2025. Revenue has grown at a 22.6% compound annual rate over the past 9 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.09 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $109.8M | $38.3M | $64.4M | $48.0M | $48.0M | $18.0K | $8.2M | $1.1M | $8.2M | $17.5M |
| Cost of Revenue | $12.4M | $9.4M | $7.7M | $5.2M | $5.2M | $1.0M | $600.0K | $1.8M | $600.0K | $28.0K |
| Gross Profit | $97.3M | $33.6M | $56.7M | $42.9M | $42.9M | $18.0K | $7.6M | -$675.0K | $7.6M | $17.5M |
| SG&A Expense | $155.1M | $93.3M | $82.8M | $87.5M | $87.5M | $60.2M | $8.8M | $39.6M | $8.8M | $6.4M |
| R&D Expense | $67.1M | $45.6M | $52.9M | $47.6M | $47.6M | $49.3M | $18.7M | $36.9M | $18.7M | - |
| Operating Income | -$124.9M | -$65.5M | -$79.0M | -$92.3M | -$92.3M | -$109.5M | -$19.9M | -$77.2M | -$19.9M | $798.0K |
| Income Tax | $78.0K | $3.9M | $1.8M | $1.4M | $1.4M | $3.4M | $19.0K | $125.0K | $19.0K | - |
| Net Income | -$153.5M | -$54.3M | -$109.8M | -$110.8M | -$110.8M | -$105.1M | -$20.0M | -$75.7M | -$20.0M | -$1.9M |
| EPS (Basic) | -$2.96 | -$2.33 | -$4.81 | -$4.96 | - | - | - | - | - | - |
| EPS (Diluted) | - | - | - | - | -$5.90 | -$5.12 | -$2.14 | -$1.91 | - | - |
| Shares Outstanding | 42.2M | 32.5M | 23.1M | 22.5M | 22.2M | 21.0M | 16.2M | 13.8M | 9.7M | 2.3M |
| Gross Margin | 88.7% | 87.7% | 88.1% | 89.3% | 89.3% | 100.0% | 92.7% | -59.8% | 92.6% | 99.8% |
| Operating Margin | -113.7% | -171.0% | -122.8% | -192.1% | -192.1% | -608211.1% | -244.6% | -6842.2% | - | 4.6% |
| Profit Margin | -139.8% | -141.8% | -170.6% | -230.7% | -230.7% | -584144.4% | -245.2% | -6707.2% | - | -11.1% |